Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
---|---|---|---|---|---|
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 2310 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3440 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3650 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 5820 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 6300 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 6940 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 8190 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 9260 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 9820 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 11000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 11300 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 14200 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 14300 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 14900 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 18700 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 18800 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 18800 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 19700 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 20000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 21100 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 30500 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 30600 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 34300 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 35800 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 36500 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 36900 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 46700 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 48600 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 57300 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 61300 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 68500 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 94800 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 105000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 113000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 131000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 185000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 370000 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 382000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 484000 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 611000 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 629000 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 752000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 838000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 877000 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 946000 | Peak area | CRBN -/- | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 1450000 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 1610000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 2560000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3070000 | Peak area | CRBN -/- | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3260000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3790000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 3810000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 4840000 | Peak area | CRBN +/+ | unstimulated |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 5510000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 7120000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 7360000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 8250000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 9000000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 10400000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID | 12800000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |